ID #710 Epigenetic activation of Schlafen11 renders WNT- and SHH- activated medulloblastomas sensitive to cisplatin
Manabu Natsumeda(Niigata University), Charles Eberhart(Johns Hopkins University), Yoshihiro Tsukamoto(Niigata University), Satoshi Nakata(Gunma University), Junko Murai(Ehime University), Makoto Oishi(Niigata University), Masayasu Okada(Niigata University Medical and Dental Hospital), Jun Watanabe(Niigata University)
Cited by 0
Related Papers
Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition
|Oncotarget|2016|292
CNS high‐grade neuroepithelial tumor with <i>BCOR</i> internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue
|Brain Pathology|2017|125
<i>SLFN11</i> Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma
|Clinical Cancer Research|2015|103